Cargando…

P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING

Detalles Bibliográficos
Autores principales: Garrote Ordeig, Marta, Lopez-Guerra, Monica, Arellano-Rodrigo, Eduardo, Rozman, Maria, Carbonell Ordeig, Sara, Guijarro, Francesca, Santaliestra Tomas, Marta, Triguero Moreno, Ana, Colomer, Dolors, Cervantes, Francisco, Alvarez Larran, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431255/
http://dx.doi.org/10.1097/01.HS9.0000971112.15230.81
_version_ 1785091158062399488
author Garrote Ordeig, Marta
Lopez-Guerra, Monica
Arellano-Rodrigo, Eduardo
Rozman, Maria
Carbonell Ordeig, Sara
Guijarro, Francesca
Santaliestra Tomas, Marta
Triguero Moreno, Ana
Colomer, Dolors
Cervantes, Francisco
Alvarez Larran, Alberto
author_facet Garrote Ordeig, Marta
Lopez-Guerra, Monica
Arellano-Rodrigo, Eduardo
Rozman, Maria
Carbonell Ordeig, Sara
Guijarro, Francesca
Santaliestra Tomas, Marta
Triguero Moreno, Ana
Colomer, Dolors
Cervantes, Francisco
Alvarez Larran, Alberto
author_sort Garrote Ordeig, Marta
collection PubMed
description
format Online
Article
Text
id pubmed-10431255
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104312552023-08-17 P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING Garrote Ordeig, Marta Lopez-Guerra, Monica Arellano-Rodrigo, Eduardo Rozman, Maria Carbonell Ordeig, Sara Guijarro, Francesca Santaliestra Tomas, Marta Triguero Moreno, Ana Colomer, Dolors Cervantes, Francisco Alvarez Larran, Alberto Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431255/ http://dx.doi.org/10.1097/01.HS9.0000971112.15230.81 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Garrote Ordeig, Marta
Lopez-Guerra, Monica
Arellano-Rodrigo, Eduardo
Rozman, Maria
Carbonell Ordeig, Sara
Guijarro, Francesca
Santaliestra Tomas, Marta
Triguero Moreno, Ana
Colomer, Dolors
Cervantes, Francisco
Alvarez Larran, Alberto
P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING
title P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING
title_full P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING
title_fullStr P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING
title_full_unstemmed P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING
title_short P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING
title_sort p1054: clinical characteristics and outcomes in 175 patients with myelofibrosis according to genomic classification using next-generation sequencing
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431255/
http://dx.doi.org/10.1097/01.HS9.0000971112.15230.81
work_keys_str_mv AT garroteordeigmarta p1054clinicalcharacteristicsandoutcomesin175patientswithmyelofibrosisaccordingtogenomicclassificationusingnextgenerationsequencing
AT lopezguerramonica p1054clinicalcharacteristicsandoutcomesin175patientswithmyelofibrosisaccordingtogenomicclassificationusingnextgenerationsequencing
AT arellanorodrigoeduardo p1054clinicalcharacteristicsandoutcomesin175patientswithmyelofibrosisaccordingtogenomicclassificationusingnextgenerationsequencing
AT rozmanmaria p1054clinicalcharacteristicsandoutcomesin175patientswithmyelofibrosisaccordingtogenomicclassificationusingnextgenerationsequencing
AT carbonellordeigsara p1054clinicalcharacteristicsandoutcomesin175patientswithmyelofibrosisaccordingtogenomicclassificationusingnextgenerationsequencing
AT guijarrofrancesca p1054clinicalcharacteristicsandoutcomesin175patientswithmyelofibrosisaccordingtogenomicclassificationusingnextgenerationsequencing
AT santaliestratomasmarta p1054clinicalcharacteristicsandoutcomesin175patientswithmyelofibrosisaccordingtogenomicclassificationusingnextgenerationsequencing
AT trigueromorenoana p1054clinicalcharacteristicsandoutcomesin175patientswithmyelofibrosisaccordingtogenomicclassificationusingnextgenerationsequencing
AT colomerdolors p1054clinicalcharacteristicsandoutcomesin175patientswithmyelofibrosisaccordingtogenomicclassificationusingnextgenerationsequencing
AT cervantesfrancisco p1054clinicalcharacteristicsandoutcomesin175patientswithmyelofibrosisaccordingtogenomicclassificationusingnextgenerationsequencing
AT alvarezlarranalberto p1054clinicalcharacteristicsandoutcomesin175patientswithmyelofibrosisaccordingtogenomicclassificationusingnextgenerationsequencing